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Background: Integrin-linked kinase (ILK) is a serine-threonine kinase that transduces extracellular matrix-related
cues into intracellular signals, with fundamental roles in cell motility, development and cancer. Recently ILK been
shown to have an important role in bacterial epithelial cell attachment, through ILK-bacterial OspE binding. Here
we report on the role of epithelial derived ILK in response to Citrobacter rodentium infection.
Methods: C. rodentium was administered to both control and intestinal epithelial cell ILK knockout mice.
Histological inflammatory scores were assessed, and cytokines measured by ELISA as well as RT-PCR, in mouse
colons. Bacterial colonization was determined by plating homogenates onto MacConkey agar, and
immunofluorescence microscopy performed using anti-LPS and anti-Tir antibodies.
Results: ILK-ko mice exhibited reduced weight loss at 15 days post-infection (p < 0.01) and demonstrated reduced
histological inflammatory scores (p < 0.01), reduced CCL2 and pro-inflammatory cytokines. This was not due to
reduced colonization, but was associated with an altered pattern of C. rodentium bacterial migration. Attenuated
fibronectin expression was found in the ILK-ko mice. C. rodentium exposure was shown to increase ILK expression in
cell lines, and in murine epithelium in vivo. In ILK-ko mice reduced activation of ser473Akt and reduced crypt
proliferation, together with reduced cyclin D1 expression were observed.
Conclusions: ILK influences the host response to C. rodentium -induced infection, independently of reduced
colonization in the ILK knockout mice. The reduced inflammation and dramatically attenuated hyperplastic cryptal
response to infection in this group, are at least in part the result of, the reduction in CCL2 and cyclin D1 expression
respectively.
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Gastrointestinal infection is an important cause of mortality
in the developing world and morbidity in the developed
world [1,2]. Although a variety of bacteria and viruses are
known to cause gastroenteritis, the underlying mechanisms
involved remain unknown. Several barriers are known
to mitigate against intestinal infection and these include
physical defenses such as the surface mucus layer, cell-
cell junctions, rapid epithelial cell turnover, the presence
of commensal bacteria, as well as the innate immune sys-
tem responsible for the production of immunoglobulin A,
defensins and resident immune cells [3,4]. Infection occurs* Correspondence: bill.salh@ubc.ca
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reproduction in any medium, provided the orwhen organisms are successfully able to breach these
barriers. Some of the most important organisms causing
bacterial infection world-wide are Enteropathogenic and
enterohaemorrhagic Escherichia coli (EPEC and EHEC
respectively). An organism that is useful to study mechan-
istic aspects of this process is C. rodentium, colonization
by which results in epithelial injury through the develop-
ment of development of F-actin-rich pedestals, otherwise
known as attaching and effacing lesions in mice [5,6]. This
process is known to rely on a type III secretion system
used to inject bacterial effectors into host epithelium. Due
to similarities with human idiopathic inflammatory bowel
disease, such as a predominant Th1 response, attended by
the elaboration of cytokines such as interferon gamma,
the C. rodentium model has also been used to investigate
mechanisms involved in that group of disorders.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ing protein via a yeast 2-hybrid assay. Since then it has
been shown to play an important role in focal adhesion
formation, which it achieves by complexing with Pinch
and the Parvin proteins [7]. A significant body of work
has shown that ILK plays a role in tumor biology. Other
work indicates a role in cardiac development, blastocyst
implantation, skin, connective tissue, hepatic and gut de-
velopment [8].
ILK has been shown to be involved in the uptake of
Streptococcus pyogenes and other bacteria into epithelial
cells [9]. More recent work has shown that host intes-
tinal ILK may be subverted by Shigella flexnerii in order
to stabilize focal adhesions [10]. This facilitates blocking
of cell detachment and hence the bacteria are able to gain
a foothold for infection to proceed. An effector protein
OspE, which is conserved in enteropathogenic E. coli,
Salmonella and C. rodentium, was shown to bind to ILK
and co-localize with it at focal adhesions.
It is presently unclear exactly how ILK within the
gastrointestinal epithelium may modulate the binding
of, and response to infection with organisms such as
C. rodentium. In our previous work we have shown that
conditional knockout of ILK in epithelial cells blunts
the response to inflammation-induced cancer develop-
ment in the colon [11]. We have also demonstrated that
epithelial ILK deficiency leads to attenuation of DSS-
induced colitis, an effect that was associated with a
reduction in fibronectin expression, as well as an al-
teration in the ratios of lymphocyte populations [12].
In this work we have investigated how ILK deficiency
affects the host response to C. rodentium infection.
Methods
Anti-Tir and anti-LPS antibodies were obtained from
Dr B Vallance; anti-fibronectin antibody from Abcam
(Cambridge, MA); ILK, Akt, Gadph, actin, cyclin D and
Ki-67 antibodies from Santa Cruz (Santa Cruz, CA),
ser473 Akt from Cell signaling, ILK si-RNA from Qiagen,
Akt and ILK antibodies from Santa Cruz; anti-CD3.
ELISA kits for TNFα, IFNγ, IL-10, CCL2 were obtained
from BD Biosciences (Mississauga, ON). Horse-radish
peroxidase conjugated secondary antibodies were obtained
through Calbiochem (San Diego, CA). EGTA, EDTA,
MOPS, PMSF, sodium orthovanadate, leupeptin, aprotinin,
benzamidine, dithiothreitol and β-glycerolphosphate, were
purchased from Sigma.
ILK-ko mice, disease activities
We have previously described our ILK knockout mice
[11]. Briefly, mice on an FVB (Friend virus B-type) back-
ground were kept in conventional housing in the animal
care facility at Jack Bell Research Centre. They were fed
chow ad libitum and had liberal access to drinking water.All experiments were approved by the UBC Animal Ethics
Committee (A05-1580). Inactivation of ILK in colonic
epithelial cells was achieved by crossing the Fabp –Cre
mice with ILKflox/flox animals. The resulting offspring
were then backcrossed with the homozygote floxed mice
to generate the genotype: ILKflox/flox,Cre. Genotyping for
Cre and ILK were carried out as previously described.
Briefly, tail DNA was obtained and the following primers
used to detect Cre expression: 5′–CCTGGAAAATGCTTC
TGTCCG–3′ and 5′- CAGGGTGTTATAACAATCCC-3′.
ILK genotype was monitored using: 5′- CCAGGTGGCAG
AGGTAAGTA-3′ and 5′-CAAGAAATAAGGTGAGCTT
CAGAA-3′.
For infection experiments mice were used out at ap-
proximately 6 to 8 weeks of age. C rodentium (strain DBS
100) was given by gavage as an inoculum of 2.5 × 108 bac-
teria per 100 ul of Luria broth and the mice terminated
either on day 6 or 15.
Their colons were examined for macroscopic and,
using hematoxylin and eosin, for microscopic disease
activity as previously described with some modifications
[13]. After removal, the colons were fixed in 10% buffered
formalin for immunohistochemistry, protein lysates were
prepared for western analysis and ELISA. With reference
to disease activity scoring: A. Macroscopic assessment
of disease activity was scored from 0–4 as follows: 0, no
signs of inflammation, normal pellet, and from 1–4
depending on the degree (slight, moderate, severe) of
liquidity of stool, presence of hyperemia and thicken-
ing of the distal bowel, presence of blood, as well as
the degree of weight loss. B. Microscopic scores were
scored by a gastroenterological pathologist with experi-
ence in murine mucosal pathology (D Owen). This score
grades the severity of the lesion from 0–4, based on the
severity of inflammation, the extent of inflammation
(depending on mucosal → transmural inflammation),
ulceration, crypt damage, and percentage involvement
observed across 5 different microscopic fields per mouse.
SDS-polyacrylamide gel electrophoresis
Western immunoblotting was performed as previously
described [12]; colonic tissue or cultured cells were ho-
mogenized in buffer containing 20 mM MOPS, 150 mM
NaCl, 50 mM β-glycerophosphate, 5 mM EGTA, 50 mM
NaF, 1 mM DTT, 1 mM sodium vanadate, 0.5% NP40
and 1 mM PMSF. After sonicating for 15 s (×2) and cen-
trifuging at 14,000 RPM for 15 min, the protein concen-
tration in the supernatant was determined by the Bradford
assay (Bio-Rad, Mississauga, Ont). 25 ug of protein from
each sample was resolved using 10% SDS-PAGE before
transferring to nitrocellulose membranes (Bio-Rad). The
blots were blocked in 5% skim milk in TBST (20 mM
Tris–HCl pH 7.4, 250 mM NaCl, 0.05% Tween-20) for 1 h
before probing for 2 h using the appropriate primary
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three times, before being incubated with the appropriate
secondary antibody for 1 h. Following 3 further washes in
TBST, they were developed using the enhanced chemilu-
minescence detection system (ECL, Amersham, Montreal,
Quebec).
Immunohistochemistry
Paraffin-embedded colonic tissue samples were de-waxed
in xylene twice for 5 min, rehydrated in a series of ethanol
(100% - 70%) for 3 min each followed by rehydration in
PBS for 30 min. After rehydration the endogenous perox-
idase was blocked with 0.3% hydrogen peroxide followed
by antigen retrieval by microwaving sections in citrate buf-
fer pH 6.0 (10 mM Na citrate). Following antigen retrieval,
the sections were washed three times with PBS, blocked
in 1% BSA for 1 h, and then stained using the Vectastain
ABC kit (Vector laboratories, Burlingame, CA) men-
tioned below according to manufacturer’s recommenda-
tions but with the following modifications. Sections
were incubated with the following primary antibodies
at 4°C overnight: cyclin D1 (Santa Cruz, CA), fibronec-
tin (1:200, Abcam, Cambridge, MA), Ki-67. Following
incubation, the sections were rinsed three consecutive
times with PBS and then incubated with the appropriate
biotinylated secondary antibody for 1 h followed by
incubation with peroxidase-labelled streptavidin. Nova –
red and DAB were used as the chromagens, and the
sections were counterstained with haematoxylin. Three
blinded observers independently examined all stained
sections [12].
For detection of Tir and LPS by immunofluorescence,
the slides were processed as for IHC and the following
antibodies were used: Tir and LPS (Vallance). Sections
were stained with Vectastain ABC elite kit and biotinylated
ant-rabbit for DAPI, or eFluor650 Nanocrystal conjugation
kit, cat no. 88-7072-98 antibody, and Avidin D-FITC (or
Avidin-Texas Red) used for immunofluorescence (Vector
laboratories, CA, USA). A Zeiss LSM-780 microscope was
used to capture images. Each section had its own control
using the secondary antibody only. Pre-immune serum was
initially used to ensure specificity of the signal with each
of the antibodies.
Cell culture
HCT 116 cells were a kind gift of Bert Vogelstein (Johns
Hopkins, Baltimore, Maryland) and were cultured in
McCoys 5A Medium (Gibco, Burlington, Ontario) con-
taining 10% heat inactivated fetal bovine serum (FBS)
(Hyclone, Logan, Utah). Protein lysates were obtained
using homogenization buffer as described above.
CMT93 cells are derived from a murine rectal cancer
and were obtained from B Vallance (Vancouver, BC).
They were cultured in DMEM containing 10% FBS and2 mM glutamine; experiments were performed when cells
were approximately 90% confluent.
Semiquantitative RT –PCR
1 ug of RNA, obtained using Trizol from HCT 116 cells
(or murine colon), was reverse transcribed using random
hexamers (Perkin-Elmer Applied Biosystems, Branchburg,
NJ) and 20 units of Moloney murine leukemia virus
reverse transcriptase M-MLV (Invitrogene) in 20 μl of
total volume at 25°C for 10 min and at 37°C for 60 min.
The resulting first-strand complementary DNA (cDNA)
was used as template for the semi- quantitative-PCR.
Amplification of the following cDNAs was performed




of gene expression was performed using densitometry and
beta-actin as a control.
Si-RNA-mediated knockdown of ILK
This was performed as described previously using a 21-mer
to transfect HCT116 cells, grown to 60% confluency, using
Silentfect (Biorad). Two separate ILK si-RNA and control
(scrambled) sequences were purchased from Qiagen Inc
(Mississauga, ON), and from Santa Cruz Biotechnology
Corporation Inc (Santa Cruz, Ca). Gene knockdown was
confirmed using western blotting and Q-PCR.
Bacterial counts
After homogenization of either cecal or colonic tissue,
or stool pellets, they were serially diluted. They were
then plated onto MacConkey agar plates and bacterial
colonies were enumerated after 1 day [14].
Statistical analysis
All macroscopic and histological disease scores, as well
as cytokine levels were expressed as mean + SD, with
p < 0.05 being considered significant using the Student’s
t-test (unpaired, two-tailed). Where indicated ANOVA
was performed with Tukey post-hoc testing.
Results
C. rodentium induces ILK and activates Akt in epithelial cells
Our first objective was to investigate if bacterial exposure
of epithelial cells led to any change in the levels of expres-
sion of ILK. CMT 93 cells were exposed to C. rodentium
and cells were harvested at the time points shown
(Figure 1A). As the data indicates this led to an increase
in the expression of ILK without affecting the levels of
Akt, an important kinase involved in cellular survival.
However there is a clear increase in the intensity of the
ser473 Akt signal, the site known to be critically involved
in its activation. In order to address whether ILK was
Figure 1 ILK is induced in response to C. rodentium exposure of CMT 93 cells, together with activation of Akt, and ILK regulates Akt
activation in response to LPS. A. Colonic CMT 93 cells were exposed to C. rodentium for the times indicated. Cellular protein was obtained by
lysing cells in homogenization buffer, and western blotting performed for the molecules indicated. B. After knocking down ILK using si-RNA
(or scrambled control oligo) HCT116 cells were stimulated with LPS (1 ug/ml) for 30 min and western immunoblotting performed. GAPDH and
β-actin were used as the loading controls.
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cells. We have found that these cells respond reliably to
LPS and have been able to knock down ILK using si-RNA
in this system. The data (Figure 1B) shows that knock-
down of ILK attenuates the response of these cells to LPS
induced ser473 Akt activation. Collectively these findings
indicate that epithelial cells have the capacity to activate
Akt via ILK.
C. rodentium –induced colitis is attenuated in ILK-ko mice,
and ILK is induced in response to infection
The C. rodentium induced murine colitis model is a very
well characterized system to investigate host-microbial
interactions, as well as the ensuing inflammatory response.
A mild colitis usually results after 10 to 15 days post-
infection, which is usually accompanied by a mild degree
of weight loss [15], however a fatal form of the disease,
characterized by severe inflammation has been described
in the FVB strain [16]. We investigated this in our ILK-ko
mice in comparison with their littermate control mice.
The data (Figure 2A) obtained from six mice per group,
indicates that the weight-loss response is attenuated in the
ILK-ko mice. In Figure 2B there is a clear reduction of
macroscopic inflammation in the knockout mice. Similar
changes were seen at the level of histological inflammation
(Figure 2C). In order to verify that there was an induction
of ILK protein in response to C. rodentium in vivo we
performed a time course experiment. Using mucosal
scrapes from mice terminated at days 1–3, and western
immunoblotting, we observe an increase in ILK at be-
tween 2–3 days (Figure 2D). A comparison of the levels
of ILK present in the 2 sets of mice used in these stud-
ies, shows a difference at the end of 15 days (Figure 2E).
Whilst both panels show positive staining within theimmune cells coursing between the crypts, there is a
clear reduction of the ILK signal from the epithelial
cells, in the representative ILK-ko example shown.
C. rodentium induces CCL2 and macrophage infiltration;
both of which are blunted in ILK-ko mice
We next characterized the levels of expression of CCL2
in these groups. We have shown that this chemokine is
reduced in another model of colitis induced by dextran
sodium sulfate. As we have previously shown that ILK
may impact on the level of expression of CCL2 expres-
sion by RT-PCR in an epithelial system, this was investi-
gated in this model also. Similar to our findings in the
DSS-induced colitis, we showed a reduction of CCL2 in
the ILK-deficient mice, both at the level of message and
protein (Figure 3A/B). To determine whether or not this
was associated with any change in infiltration of cells of
the monocytic series, we performed immunohistochemistry
with the F4/80 antibody, which recognizes monocytes and
macrophages. The data clearly shows an impressive number
of cells in the submucosa of the wild-type mice, which are
missing in the ILK-ko example shown. Typical histological
sections (Figure 3D) show the crypt hyperplastic response
together with inflammation in the wild-type mouse, which
is blunted in the ILK-ko section shown.
ILK-ko mice have reduced levels of pro-inflammatory
cytokines
Measurement of key cytokines, representative of pro- and
anti-inflammatory effectors, tumor necrosis factor alpha
(TNFα), interferon gamma (IFNγ) and interleukin 10
(IL-10), revealed that there were significant reductions
in TNFα and IFNγ in the knockout mice, which was asso-
ciated with an increase in the level of IL-10 (Figure 4A-C).
Figure 2 ILK-ko mice are protected from C. rodentium induced wasting disease and inflammation, and exhibit reduced expression of
the chemokine CCL2. A. Colitis was induced in 6 animals per group by administering C. rodentium by gavage. Animal weights were recorded
daily. There was an observed significant difference in their weights from days 13–15 (p < 0.05). B. Assessment of macroscopic damage in ILK-ko
mice (day 15) indicated a significant reduction in comparison to control mice (**p < 0.01). C. Microscopic damage scores (day 15) were determined
using criteria outlined in Materials and methods, based on severity and extent of inflammation. The data indicate there was reduced damage in the
ILK-ko mice. D. ILK expression was assessed in response to Citrobacter at the time points indicated using western immunoblotting. The representative
data indicated an increase in ILK expression after 48–72 hours (b-actin is shown as a loading control). E. ILK immunohistochemistry is shown 15 days
post-infection in a wild-type and ILK-ko sample. There is a reduction in the ILK signal intensity in the epithelial cells as compared with the comparable
intensity in the infiltrating immune cells.
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in the epithelial cell component, directly or indirectly, is
associated with a reduced inflammatory cytokine response
due to C. rodentium.
ILK-ko mice have diminished Akt activation in response
to C. rodentium
Next we wanted to assess the impact of inflammation on
the expression of key ILK regulated proteins in the intes-
tine. In accordance with the data in the cell lines, we
observed an attenuation of the activation of Akt in the
ILK-ko mice, as well as a reduction in the level of expres-
sion of the transcription factor Snail, but not E-cadherin,
using western blotting (Figure 5A/B). Previous work has
shown that expression of Snail and E-cadherin, can be
modulated by ILK in epithelial cells [17]; ILK impactingon Snail expression thereby de-repressing E-cadherin
expression. Furthermore we have shown a correlation
between Snail and ILK-ko in a colitis - associated cancer
model, where the ILK-ko mice had reduced expression
of Snail in the neoplasms [11]. These findings indicate
that genetic deletion of ILK in epithelial cells results in
attenuation of the Akt activation response and Snail
expression, although regulation of E-cadherin may be
more complex.
C. rodentium binding to apical epithelium is unimpaired
in ILK-ko mice
Based on these findings we hypothesized that perhaps
the blunted inflammatory and response to C. rodentium
was due to impaired epithelial binding in the knockout




Figure 3 ILK-ko mice exhibit reduced expression of the chemokine CCL2, and reduced monocyte-macrophage influx. A. CCL2 induction
(RT-PCR, message compared to that of β-actin) was significantly (**p < 0.01) reduced in the ILK-ko group. B. Distal colonic lysates (pooled) were
used to determine CCL2 levels by ELISA. The data are for 6 mice per group and show a reduction in levels of CCL2 in the ILK-ko mice (*p < 0.01).
C. IHC for F4/80 which is a marker for cells of the monocyte/macrophage lineage shows reduced numbers in the ILK-ko mice. D. Histology of a
representative section from each of the WT and ILK-ko mice shows less inflammation and hyperplasia in the ILK-ko example shown. Notably,
there are elongated crypts seen in the ILK-ko mice as can be seen to the right side of the ILK-ko panel.
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luminal contents and in the mucosal lining. As the data in
Figure 6 (A/B) indicate there appears to be no difference
in the levels of bacteria in the two sets of mice, regard-
less of whether the colonic (or cecal) contents or tissue
were examined. This clearly indicates that the responses
observed must be occurring at or distal to the epithelial
cell system in the mice, and importantly, that the responses
were not simply due to a failure of the C. rodentium
to bind.
C. rodentium cryptal migration is impaired in ILK-ko mice
In order to verify that bacterial binding occurred in a
similar distribution in the two sets of mice we performed
immunofluorescence using previously described antibodies,
one against C. rodentium LPS (green) and the other againstTIR (red); the latter being a widely recognized method for
demonstrating C. rodentium infection. The upper panels
(Figure 6C) depict representative staining in the wild-type
mice. As can be seen bacterial binding occurs at the apical
surface and appears to migrate downwards along the lateral
aspects of the crypts. In the lower panels for the ILK-ko
mice (Figure 6D), it is evident that bacteria are able to bind
to the apical region, however, there does not appear to
be a comparable signal migrating downwards. This may
be a factor in the reduced inflammatory response ob-
served. In order to determine whether the response was
being delayed in the ILK-ko mice we repeated the ex-
periment at day 14. The data again show no significant
differences in bacterial binding, or any increased migra-
tion at this later time-point (Figure 7A-C). This intri-
guing observation at 2 different time-points, indicates that
Figure 4 ILK-ko mice express reduced pro-inflammatory cytokines. A-C. Distal colonic lysates (pooled) were used to determine TNF alpha,
IL-10 and IFN gamma levels by ELISA. The data are for 6 mice per group and show a reduction in levels of TNF alpha and IFN gamma, as well as
an increase in IL-10 in the ILK-ko mice (*p < 0.05).
Figure 5 ILK-ko mice have reduced Akt activation, and reduced expression of Snail, but not E-cadherin after C. rodentium induced
colitis. A. Lysates prepared from distal colonic homogenates were resolved using Western analysis and the resulting membranes probed with
the antibodies indicated (4 mice from ILK-ko and littermate controls). B. Densitomtry was performed and the resulting data is depicted in the
barcharts (Akt, Snail and E-cadherin).
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Figure 6 Effects observed in ILK-ko mice are not due to impaired binding of C rodentium. ILK-ko and control mice were gavaged with
C. rodentium and their cecal and colonic tissues assessed for levels of C. rodentium by plating homogenates and counting the number of
colonies, in both the colon (A) and cecum (B). The tissues were also processed for immuno-fluorescence and probed with antibodies to LPS
(green) and Tir (red), and overlayed (yellow). As can be seen bacteria are capable of binding in the ILK-ko mice but may be impaired in their
ability to migrate downwards in between the crypts (C/D).
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ing, facilitates the intercryptal migration of bacteria.
C. rodentium –associated hyperplasia is reduced in
ILK-ko mice
As one of the key mechanisms involved in prevention of
bacterial adherence by epithelia is related to increased
epithelial cell turnover, we explored cellular proliferation
using Ki-67 immunohistochemistry, in the ILK-ko and
littermate control wild-type mice. As the representative
pictures show there is clearly more enhanced proliferation
in the wild-type versus the knockout mice (Figure 8A/B).
The data in the barchart (Figure 8C) show the positive
staining in the knockout mice is less than half of that seen
in the wild-type mice. The crypt heights were measured
and there was a clear reduction at both the 6 and 15 day
time-points, in the ILK-ko mice. Interestingly, we noted
an increase in the crypt height between the 2 time-
points in the ILK-ko mice indicating that perhaps aFigure 7 Effects observed in ILK-ko mice are preserved at day 14 pos
and their cecal and colonic tissues assessed (day 14) for levels of C. rodenti
for Figure 6 (A/B). The tissues were also processed for immuno-fluorescenc
still equivalent amounts of bacterial bainding, bacteria are still unable to m
second time-point.delayed response to the bacteria was occurring. How-
ever as the data in Figure 8 indicate, there was no differ-
ence in the binding/distribution patterns at this later
timepoint.
In order to determine the specific role of cyclin D1, a
target of ILK, in this response we utilized immunohisto-
chemistry. The data indicates (Figure 9) that the level of
cyclin D is reduced in the ILK-ko mice, a finding in
keeping with changes observed and previously reported
by us in the ILK-ko mice in response to induction of
cancer-associated colitis.
Reduced C rodentium –induced fibronectin expression in
ILK-ko mice
The extracellular matrix may be an important determin-
ant of bacterial ability to infect epithelial systems. In this
regard a number of different bacteria utilize fibronectin to
aid binding and/or invasion, whilst some are capable of
expressing fibronectin-binding proteins [18]. As others,t-infection. ILK-ko and control mice were gavaged with C. rodentium
um by plating homogenates and counting the number of colonies as
e in the same manner (C/D). It can be seen that although there are
igrate downwards in between the crypts, in the ILK-ko mice at this
Figure 8 Reduced proliferation in ILK-ko mice in response to C. rodentium. infection. A, B. Sections were processed for immunohistochemistry
using an antibody to Ki-67 at the time-points indicated. The photomicrographs are representative of data from 5 mice. C. The number of Ki-67 positive
cells per crypt were counted in 5 HPFs at days 6 and 15. D. Crypt heights were measured using a micrometer in 5 different fields, in each of 5 mice
per group.
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thelial expression of fibronectin [19], we explored the pos-
sibility that this was the case in this system also. We have
shown using immunohistochemistry that in the DSS-
induced colitis model there is significantly less fibronectin
expression in the ILK-ko mice. When we assessed this in
the C. rodentium -induced colitis model we observe a
similar finding, specifically that fibronectin expression is
downregulated in the ILK-ko mice (Figure 10). This may
be another mechanism to explain the reduced migration
of the bacteria downwards between the crypts.
Discussion
In this report we have added to our understanding of
the role of ILK in intestinal pathophysiology, specifically
in the setting of bacterial infection. Similar to the find-
ings reported for DSS-induced colitis we show that there
is a reduced inflammatory response, associated with a
reduction in CCL2 expression, an important immune
cell chemoattractant. Furthermore, our findings indicate
that the pattern but not the magnitude of epithelial C.
rodentium binding is altered in the ILK-ko mice, with
preserved apical binding but reduced lateral epithelialcell binding/migration, in between adjacent crypts. Al-
though the reduced expression of fibronectin may ac-
count for this finding, we cannot exclude alterations in
other extracellular matrix components, or alterations in
the levels of other cell surface integrins as being involved
in this response. An additional role for ILK is indicated
by the reduced crypt hyperplasia observed associated
with decreased cyclin D1 on immunohistochemistry, in
ILK-ko mice.
Bacteria utilize multiple mechanisms to gain a foothold
facilitating their colonization, and several of these involve
components of the extracellular matrix and integrin net-
work [20]. The production of bacterial fibronectin-
binding proteins (FnBPs) enables pathogens to bind host
cell integrins through a fibronectin bridge. Organisms
such as Yersinia pseudotuberculosis and Shigella flexneri
undergo ingestion via integrin receptors. Streptococcus
pyogenes uses M1 or PrtF1 surface proteins bound to
fibronectin, to facilitate invasion via the α5β1 integrin
receptor. As ILK interacts with the cytoplasmic domain
of β1 integrin, this places ILK in a unique position to
mediate downstream signaling. In the case of C. rodentium
we can demonstrate equivalent levels of apical epithelial
Figure 9 Reduced cyclin D1 expression in ILK-ko mice in
response to C rodentium infection. Sections were processed for
immunohistochemistry using an antibody to cyclin D1. The number
of positively staining nuclei in 5 crypts per mouse in each of 5 mice
were counted at days 6 and 15 (black: WT, grey:ILK-ko).
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bacterium is impaired. This leads us to suspect that
other receptors (possibly ILK-dependent integrins) are
required for this. Future work will attempt to examine
which integrins are specifically regulated by ILK in the
intestinal epithelium.A C
B
Figure 10 Reduced fibronectin expression in response to C rodentium
as described in Methods, fibronectin scoring was performed by examinati
0- no signal; 1- less than 10% of field, low intensity; 2-between 10-50% of
example shown, the ILK-ko has been scored as 1, and for the WT sample,OspE is a virulence factor common to several pathogens,
including C. rodentium, EPEC, EHEC and Salmonella spe-
cies, and is injected into host cells by the type III secretion
system [21]. This has recently been shown to bind to ILK,
resulting in an increase in the number of focal adhesions;
OspE and ILK were shown to co-localize at focal adhesions
through vinculin staining. It also caused an increase in the
cell surface levels of β1 integrin, whilst at the same time
reducing phosphorylation of focal adhesion kinase (FAK)
and paxillin [10]. Together, this results in stabilization
of focal adhesions and thereby facilitates bacterial cell
adherence, through an attenuation of cell shedding. Our
findings do not indicate a specific defect in bacterial ad-
herence in ILK-ko mice, indicating that for C. rodentium
this may not be a critical event. However there were clear
differences in bacterial migration, indicating other (bacterial-
mediated) ILK-dependent events that may be important.
We cannot exclude the possibility that the effects we
observe are the sum of two opposing events, the first
due to a primary ILK-dependent reduction in cellular
turnover thereby facilitating bacterial binding, and the
second due to a reduction in ILK and OspE mediated
reduction in bacterial binding.
Recent work has characterized the role of another
important matrix protein, osteopontin (OPN) in the
development of murine intestinal inflammation [22]. This
has been previously shown to be upregulated in inflamma-
tory bowel disease, but the exact significance of this
observation remains unknown. In that work, OPN was
induced in response to infection with C. rodentium, and it
was noted that mice lacking OPN were colonized to ainfection in ILK-ko mice. After performing immunohistochemistry
on of 5 HPFs in 4 mice from each group, using the following criteria:
field, moderate intensity; 3- over 50% of field, highest intensity. In the
2 (A/B). The overall data is shown in C.
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controls. Consequently reduced pedestal formation and
epithelial proliferation were observed and the former was
reversed by the administration of human OPN. This
indicates that bacteria have varying degrees of depend-
ence on extracellular matrix components in facilitating
their colonization, since apically at least we observed
equivalent levels of binding (Figures 6 and 7), despite
reduced fibronectin levels in ILK-ko mice.
Interestingly, infection with C. rodentium has not been
associated with profound changes in apoptosis. This may
be related to activation of the phosphatidylinositol 3-
kinase (PI3K), a growth factor and TNFα -activated lipid
kinase, which is associated with a cellular survival response.
Using a pharmacological inhibitor Ly294002 it has been
shown that PI3K is required for the host response for
bacterial clearance, as well as the epithelial proliferative
response [23]. This was reported to occur without any
changes in inflammation. As previous work indicates
that ILK is downstream of PI3K, some of our observa-
tions mirror these findings (reduced hyperplasia) whilst
others may be dissociated from PI3K, most notably, the
reduced inflammation in conjunction with the effect on
the extracellular matrix.
Presently it is not known what specific molecules are
involved in the sensing of epithelial damage and the
resulting effectors of epithelial proliferation (and/or re-
pair). The reduced epithelial proliferation consequent
upon C. rodentium infection observed in our study may
be due to 2 reasons. Firstly, because ILK is involved in
the regulation of cyclin D1 this may be a direct effect at
the level of the epithelial cell and independent of any
bacterial-mediated mechanism [24]. As β-catenin is acti-
vated in response to C rodentium infection [25], and its
casein kinase 1 (CK1) -mediated serine phosphorylation
on residue 45 appears to coincide with hyperplasia [26],
it is likely that cyclin D1 is activated directly in response
to this. However in the FVB strain mice used in our work
we were unable to demonstrate nuclear localization of
β-catenin at either of the time-points investigated (days
6 or 15). The second reason may be an indirect one, and
it is hypothesized to occur via the inability of the bac-
teria to migrate downwards in the ILK-ko in a similar
manner to that observed in the wild-type mice.
Using Swiss Webster mice it has been shown that
NF-κB is activated in response to infection with
C. rodentium, and importantly that this is not corre-
lated with the observed hyperplastic response. This was
initially reported with the NF-κB inhibitor Velcade, which
was demonstrated to inhibit NF-κB activation only [27].
More recently it has been shown that Mek, a component
of the TLR4-Mek-MAPK pathway may mediate activation
of NF-κB in vivo, demonstrated using the Mek1/2 inhibi-
tor PD98059 [28].Our study raises some important questions about the
role of ILK in intestinal physiology and pathophysiology.
We, and others have shown that ILK is upregulated at
the protein level in intestinal and other tumors, indicat-
ing a role in tumorigenesis [29-31]. This is supported by
a wealth of data regarding ILK’s role in various proper-
ties fundamental for cancer development such as prolif-
eration, avoidance of apoptosis, angiogenesis and EMT.
Our previous work using a colitis-associated cancer model
showed a trend towards smaller tumors in ILK-ko mice
that, was accompanied by a reduction in both cyclin D
and Snail expression. This has been replicated in the
model described in this report, which is also character-
ized by profound changes in cellular proliferation, indi-
cating an important role for ILK in these two processes
in the intestine. The reduction in Snail expression,
which has been linked to EMT [32], in our ILK-ko mice
is also of interest as the FVB strain of mice are known
to undergo more fibrosis [15], and this is attenuated in
the ILK-ko mice.
Conclusions
Our findings indicate that C rodentium -induced colitis
is impaired in mice lacking expression of ILK within the
colonic epithelium. This appears to be dependent upon,
or at least associated with, a reduction in epithelial pro-
liferation as well as a reduction in inflammation. How-
ever, the observed effects do not appear to be related to
impaired bacterial binding to the apical epithelium.
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